The International Journal of Tuberculosis and Lung Disease

18 papers4 directions
The International Journal of Tuberculosis and Lung Disease (IJTLD) is a research venue focused on respiratory health, with a specific emphasis on tuberculosis, HIV co-infection, and chronic obstructive pulmonary disease. Active from 2011 through 2025, the journal publishes work concerning clinical management, public health policy, and epidemiological risk factors. Notable contributors to the venue include Amrita Daftary, Jennifer Zelnick, and K. Rivet Amico, among others. In the context of machine learning and artificial intelligence, the journal serves as a platform for evaluating the implementation of digital health technologies in respiratory medicine. Research in this area includes the assessment of automated diagnostic tools, such as CAD4TB software, and the utilization of digitized programmatic data to improve tuberculosis research outcomes. These studies often address the technical requirements for software regulation and the practical application of triaging thresholds in clinical environments. The venue also documents the intersection of biological research and social health determinants. Published papers cover diverse topics ranging from the relationship between Toll-like receptor 4 and type-2 diabetes to the impact of smoked drug use on bacterial burden in tuberculosis patients. By integrating clinical reports with data-driven analysis, the journal provides insights into the management of multidrug-resistant tuberculosis and the health experiences of specific populations globally.

Papers by Year

2025 1
2024 1
2023 2
2022 1
2021 1
2020 1
2017 1
2016 3
2015 1
2014 2
2013 1
2012 2
2011 1

Top Research Directions

Research directions most represented by papers from this venue.

The Brittleness of Static Thresholds under Distribution Shift 1
Cross-Institutional Record Linkage Without Global Identifiers 1
Common Data Models for Cross Institutional Clinical Analytics 1
Overcoming Clinical Data Fragmentation for Medical AI 1

Top Authors

AuthorPapers
Christoph Lippert1

Papers

TitleYear
Experiences of key populations in multidrug-resistant TB and HIV2025
Risk factors for severe COPD exacerbation in Chinese adults2024
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities2023
Smoked drug use in patients with TB is associated with higher bacterial burden2023
Management of childhood MDR-TB in Europe and Central Asia: report of a Regional WHO meeting2022
Advancing TB research using digitized programmatic data2021
TB and women: a call to action2020
Relationship between Toll-like receptor 4 and type-2 diabetes mellitus complicated by tuberculosis2017
Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination2016
E-cigarettes: a need to broaden the debate2016
Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV2016
Concordance of Mycobacterium tuberculosis fluoroquinolone resistance testing: implications for treatment2015
Leptin does not enhance cell-mediated immune responses following mycobacterial antigen stimulation2014
Non-communicable diseases, tobacco, and The Union2014
Position statement on electronic cigarettes or electronic nicotine delivery systems [Official statement]2013
Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care [Perspectives]2012
Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China [Short communication]2012
Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting2011